Quality of life as an outcome measure

Postgraduate Medical Journal

Volumn 73, Issue 864, 1997, Pages 613-616

  Bulpitt, Christopher J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Benefit:risk ratio; Outcome measure; Quality of life; Sickness Impact Profile

Indexed keywords

ANALYTIC METHOD; ANGINA PECTORIS; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; HEALTH STATUS; INTERMETHOD COMPARISON; MEASUREMENT; OUTCOMES RESEARCH; QUALITY OF LIFE; RELIABILITY; REPRODUCIBILITY; RISK BENEFIT ANALYSIS; SHORT SURVEY; TREATMENT OUTCOME; WELLBEING;

EID: 0030707851     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.864.613     Document Type: Short Survey

References (20)

1. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principle results. BMJ 1985; 2: 97-104.
2. Medical Research Council Working Party. MRC trial of treatment of hypertension in older adults: principle results. BMJ 1992; 304: 405-12.
3. Bergner M, Bobbin RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final version of a health status measure. Med Care 1981; 19: 787-805.
4. Hunt SM, McKenna SP, McEwan J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Commun Health 1980; 34: 281-6.
5. Kaplan RM, Bush JW, Berry CC. Health status: types of validity for an index of well-being. Health Serv Ret 1976; 11: 478-507.
6. Visser MC, Fletcher AE, Parr G, Simpson A, Bulpitt CJ. A comparison of three quality of life instruments in subjects with angina pectoris: the Sickness Impact Profile, the Nottingham Health Profile, and the Quality of Well Being Scale. J Clin Epidemiol 1994; 47: 157-63.
7. The Criteria Committee of the New York Heart Association. Diseases nomenclature and criteria for diagnosis. Boston: Little Brown, 1964; pp 110-3.
8. Lipkin D, Poole-Wilson PA. Treatment of chronic heart failure: a review of recent drug trials. BMJ 1985; 291: 993-6.
9. Parr G, Darekar B, Fletcher AE, Bulpitt CJ. Joint pain and quality of life; results of a randomised trial. Br J Clin Pharmacol 1988; 27: 235-42.
10. Fletcher AE, McLoone P, Bulpitt C. Quality of life on angina therapy: a randomised controlled trial of transdermal glyceryl trinitrate against placebo. Lancet 1988; ii: 4-8.
11. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care 1992; 30: 473.
12. Weinberger M, Kirkman MS, Samsa GP, et al. The relationship between glycemic control and health-related quality of life in patients with noninsulin-dependent diabetes mellitus. Med Care 1994; 32: 1173-81.
13. Rector TS, Kubo SH, Cohn JN. Patients' self assessment of their congestive heart failure: II content, reliability and validity of a new measure-the Minnesota Living with Heart Failure Questionnaire. Heart Fail 1987; 3: 198-209.
14. Kubo SH, Gollub S, Bourge R, et al. for the Pimobendan Multicenter Research Group. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure: results of a multicenter trial. Circulation 1992; 85: 942-9.
15. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response: effects of enalapril and placebo. Am J Cardiol 1989; 64: 50-5.
16. Croog SH, Levine S, Testa M, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657-64.
17. Fletcher AE, Bulpitt CJ, Chase DM, et al. Quality of life with three antihypertensive treatments-cilazapril, atenolol, nifedipine. Hypertension 1992; 19: 499-507.
18. Maynard A. Requirements for health care purchasers. In: Walker SR, Rosser RM, eds, Quality of life assessment: key issues in the 1990s. The Netherlands: Kluwer Academic Publishers, 1993; pp 413-26.
19. Fletcher A. Pressure to treat and pressure to cost: a review of cost-effectiveness analysis. J Hypertens 1991; 9: 193-8.
20. Johannesson M, Jönsson B. Cost-effectiveness analysis of hypertension treatment: a review of methodological issues. Health Policy 1991; 19: 55-78.